Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Ensign Group, Inc. (ENSG:NASDAQ), powered by AI.
The Ensign Group, Inc. is currently trading at $156.93. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for The Ensign Group, Inc. on Alpha Lenz.
The Ensign Group, Inc.'s P/E ratio is 26.1.
“The Ensign Group, Inc. trades at a P/E of 26.1 (premium valuation) with strong ROE of 16.9%. 3Y revenue CAGR of 18.7% highlights clear growth momentum.”
Ask for details →Ensign Group, Inc. is a distinguished entity within the healthcare industry, primarily focused on providing senior living services. The company's operations are deeply embedded in the management and development of skilled nursing and rehabilitative care facilities, catering to the needs of senior residents. As part of its extensive services, Ensign Group also offers hospice care, physical therapy, and home health services, ensuring a comprehensive approach to elder care. Through its subsidiaries, the company not only emphasizes enhancing the quality of life for its residents but also optimizes operational efficiencies across its facilities. Ensign Group holds substantial influence in the healthcare sector by maintaining facilities across multiple states, demonstrating its commitment to widespread and accessible healthcare solutions. Its strategic growth and focus on community-centric service delivery make it a significant player in the healthcare market, positively impacting patient care standards and driving advancements in elder care methodologies.
“The Ensign Group, Inc. trades at a P/E of 26.1 (premium valuation) with strong ROE of 16.9%. 3Y revenue CAGR of 18.7% highlights clear growth momentum.”
Ask for details →The Ensign Group, Inc. (ticker: ENSG) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 39,300 employees. Market cap is $9.0B.
The current price is $156.93 with a P/E ratio of 26.14x and P/B of 4.03x.
ROE is 16.91% and operating margin is 8.41%. Annual revenue is $5.1B.